Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant

Cell replacement therapy using stem-cell-derived insulin-producing β-like cells (sBCs) has been proposed as a practical cure for patients with type one diabetes (T1D). sBCs can correct diabetes in preclinical animal models, demonstrating the promise of this stem cell-based approach. However, in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shilleh, Ali H., Russ, Holger A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000642/
https://www.ncbi.nlm.nih.gov/pubmed/36899834
http://dx.doi.org/10.3390/cells12050698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000642/
https://www.ncbi.nlm.nih.gov/pubmed/36899834
http://dx.doi.org/10.3390/cells12050698

Ejemplares similares